<DOC>
	<DOCNO>NCT02021513</DOCNO>
	<brief_summary>This single blind placebo-controlled pilot study involve Systemic Lupus Erythematosus lupus nephritis patient . We propose recruit consent SLE patient randomize either receive study drug , counter fish oil supplement , placebo contains olive oil . They baseline metabolomic profile ( blood test ) , nutritional assessment , fatigue severity scale , quality life assessment , SELENA-SLEDAI lupus disease activity assessment complete time study medication distribution . Once 6 month either study drug placebo complete , pill count , assessment experience/adherence ( include side-effects , adverse effect , complaint , un-blinding ) , repeat nutritional assessment , fatigue severity scale , SELENA-SLEDAI , metabolomic profile assess . The study duration patient 6 month initiation study drug . It hypothesize patient receive fish oil supplement improvement metabolomic profile . Additionally hypothesized patient receive fish oil supplement improvement disease activity , fatigue , quality life assessment .</brief_summary>
	<brief_title>Pilot Study - Effect Omega-3 Systemic Lupus Erythematosus</brief_title>
	<detailed_description>Supplementation EPA DHA could potentially reduce inflammatory state SLE patient . This study single blind placebo-controlled pilot SLE patient 25 scheduled receive omega-3 ( EPA 2.25g/DHA 2.25g ) daily 25 schedule receive placebo ( olive oil ) , 6 month . Pre post supplementation assessment make determine EPA DHA level increase , level lipid peroxidation product , cellular energy intermediate , inflammatory marker affect EPA/DHA . Additionally , lupus disease activity , fatigue , quality life , diet assess determine parameter related metabolome SLE . - Aim 1 : - To determine metabolomic disturbance lupus patient improve follow supplementation omega-3 fatty acid . - Aim 2 : - To determine lupus disease activity , fatigue , quality life improve relate metabolomic profile change .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Male Female All ethnic group Aged 1864 Biopsy proven diagnosis Lupus Nephritis and/or fulfillment 4 American College Rheumatology criterion diagnosis Systemic Lupus Erythematosus Currently take , take last 2 month , fish oil/omega3 fatty acid/DHA/EPA Allergic fish oil , shellfish , fish product Pregnant Currently take medication : Tositumomab ( Bexxar ) Currently take anticoagulant medication ( Abciximab , Acenocoumarol , Anisindione , Ardeparin , Argatroban , Bivalirudin , Certoparin , Cilostazol , Clopidogrel , Dalteparin , Danaparoid , Defibrotide , Dermatan Sulfate , Desirudin , Dicumarol , Enoxaparin , Eptifibatide , Fondaparinux , Heparin , Lamifiban , Nadroparin , Phenindione , Phenprocoumon , Reviparin , Sibrafiban , Tinzaparin , Tirofiban , Warfarin , Xemilofiban )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>SLE</keyword>
	<keyword>Fish Oil</keyword>
	<keyword>Omega-3</keyword>
</DOC>